Pacira BioSciences, Inc.
PCRX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $148 | $300 | $284 | $277 |
| Short-Term Investments | $99 | $145 | $210 | $208 |
| Receivables | $115 | $114 | $105 | $113 |
| Inventory | $158 | $148 | $134 | $125 |
| Other Curr. Assets | $43 | $37 | $28 | $22 |
| Total Curr. Assets | $563 | $746 | $760 | $745 |
| Property Plant & Equip (Net) | $192 | $202 | $213 | $216 |
| Goodwill | $20 | $20 | $22 | $0 |
| Intangibles | $382 | $423 | $435 | $426 |
| Long-Term Investments | $0 | $19 | $0 | $0 |
| Tax Assets | $120 | $128 | $129 | $130 |
| Other NC Assets | $20 | $0 | $28 | $36 |
| Total NC Assets | $735 | $792 | $827 | $808 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $1,298 | $1,537 | $1,587 | $1,554 |
| Liabilities | – | – | – | – |
| Payables | $18 | $30 | $23 | $19 |
| Short-Term Debt | $10 | $212 | $211 | $211 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $80 | $71 | $80 | $80 |
| Total Curr. Liab. | $107 | $313 | $315 | $310 |
| LT Debt | $416 | $419 | $425 | $428 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $5 | $5 | $7 | $0 |
| Other NC Liab. | $43 | $42 | $41 | $37 |
| Total NC Liab. | $463 | $466 | $473 | $465 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $39 | $51 | $53 | $54 |
| Total Liabilities | $570 | $779 | $788 | $775 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$201 | -$206 | -$202 | -$206 |
| AOCI | $4 | $4 | $1 | $0 |
| Other Equity | $924 | $960 | $999 | $984 |
| Total Equity | $727 | $758 | $799 | $778 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $1,298 | $1,537 | $1,587 | $1,554 |
| Net Debt | $278 | $331 | $353 | $362 |